Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1-dichloroethene | increases expression | ISO | Zfp239 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of ZFP239 mRNA | CTD | PMID:26682919 | 1,2-dichloroethane | decreases expression | ISO | Zfp239 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of ZFP239 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Zfp239 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ZFP239 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Estradiol results in increased expression of ZNF239 mRNA | CTD | PMID:31614463 and PMID:36828454 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp239 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP239 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP239 mRNA | CTD | PMID:33387578 | 2-methylcholine | affects expression | ISO | ZNF239 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of ZNF239 mRNA | CTD | PMID:21179406 | 2-palmitoylglycerol | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of ZNF239 mRNA | CTD | PMID:37199045 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Zfp239 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of ZFP239 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Zfp239 (Mus musculus) | 6480464 | bisphenol S affects the methylation of ZFP239 gene | CTD | PMID:31683443 | all-trans-retinoic acid | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of ZNF239 mRNA | CTD | PMID:23724009 and PMID:33167477 | aristolochic acid A | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ZNF239 mRNA | CTD | PMID:33212167 | arsenite(3-) | increases methylation | ISO | ZNF239 (Homo sapiens) | 6480464 | arsenite results in increased methylation of ZNF239 promoter | CTD | PMID:23974009 | atrazine | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of ZNF239 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases methylation | ISO | ZNF239 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZNF239 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | ZNF239 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ZNF239 5' UTR and Benzo(a)pyrene affects the methylation of ZNF239 promoter | CTD | PMID:27901495 | bis(2-chloroethyl) sulfide | increases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Mustard Gas results in increased expression of ZNF239 mRNA | CTD | PMID:15674844 | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Zfp239 (Mus musculus) | 6480464 | Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of ZFP239 mRNA] | CTD | PMID:33484791 | bisphenol A | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of ZNF239 mRNA | CTD | PMID:36828454 | cisplatin | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ZNF239 mRNA | CTD | PMID:27392435 | cyclosporin A | increases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of ZFP239 mRNA | CTD | PMID:19770486 | diallyl trisulfide | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | diallyl trisulfide results in increased expression of ZNF239 mRNA | CTD | PMID:34995734 | diquat | decreases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Diquat results in decreased expression of ZFP239 mRNA | CTD | PMID:36851058 | folic acid | decreases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ZFP239 mRNA | CTD | PMID:25629700 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ZFP239 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of ZNF239 mRNA | CTD | PMID:20044591 | iron dichloride | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of ZNF239 mRNA | CTD | PMID:35984750 | metformin | increases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Metformin results in increased expression of ZFP239 mRNA | CTD | PMID:23457588 | methylmercury chloride | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ZNF239 mRNA | CTD | PMID:28001369 | monosodium L-glutamate | increases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Sodium Glutamate results in increased expression of ZFP239 mRNA | CTD | PMID:22078008 | morphine | increases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Morphine results in increased expression of ZFP239 mRNA | CTD | PMID:21178816 | nickel sulfate | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of ZNF239 mRNA | CTD | PMID:22714537 | ozone | multiple interactions | ISO | ZNF239 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ZNF239 mRNA | CTD | PMID:35430440 | paracetamol | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of ZNF239 mRNA | CTD | PMID:26690555 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ZFP239 mRNA | CTD | PMID:33387578 | pirinixic acid | multiple interactions | ISO | ZNF239 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ZNF239 mRNA | CTD | PMID:19710929 | potassium dichromate | decreases expression | ISO | Zfp239 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of ZFP239 mRNA | CTD | PMID:23608068 | silicon dioxide | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of ZNF239 mRNA | CTD | PMID:25895662 | sodium arsenite | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ZNF239 mRNA | CTD | PMID:22714537 | streptozocin | multiple interactions | ISO | Zfp239 (Mus musculus) | 6480464 | [Streptozocin co-treated with Dietary Fats] results in decreased expression of ZFP239 mRNA and Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of ZFP239 mRNA] | CTD | PMID:33484791 | temozolomide | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of ZNF239 mRNA | CTD | PMID:31758290 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of ZFP239 mRNA | CTD | PMID:34492290 | trimellitic anhydride | increases expression | ISO | Zfp239 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of ZFP239 mRNA | CTD | PMID:19042947 | valproic acid | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ZNF239 mRNA | CTD | PMID:24935251 | valproic acid | affects expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZNF239 mRNA | CTD | PMID:25979313 | vitamin E | decreases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of ZNF239 mRNA | CTD | PMID:19244175 | zearalenone | increases expression | ISO | ZNF239 (Homo sapiens) | 6480464 | Zearalenone results in increased expression of ZNF239 mRNA | CTD | PMID:36828454 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
